Prnewswire Senda Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Senda s SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda s leadership to support and advance the new research discipline of Intersystems Biology. This discipline focuses on how molecular connections among botanical, bacterial, and human cells coevolved over millennia define health and disease.
We are thrilled to have attracted some of the brightest minds in their fields to our SAB, says Guillaume Pfefer, PhD, chief executive officer of Senda. The deep expertise of the SAB will be pivotal to the advancement of our novel approach to medicines development, rooted in an unparalleled understanding of interspecies molecular c ....

United States , Dana Farber Cancer Institute , California Institute Of Technology , United Kingdom , University Of California San Diego , Steve Jacobsen , Roger Innes , Wendy Garrett , Ramnik Xavier , Los Angeles , Prnewswire Senda Biosciences , Guillaume Pfefer , Randy Schekman , James Rothman , Senda Biosciences , Wendys Garrett , Luke Oneill , Vijay Kuchroo , Royal Society , University Of Colorado Boulder , Trinity College Dublin , Inflammation Research Group , International Cytokine , University Of Cambridge , Immunologic Diseases At Harvard Medical School , American Association For The Advancement Of Science ,